Literature DB >> 8160776

K-ras mutations and p53 alterations in neoplastic and nonneoplastic lesions associated with longstanding ulcerative colitis.

P Chaubert1, J Benhattar, E Saraga, J Costa.   

Abstract

We have analyzed K-ras mutations and p53 alterations in 39 tumor and nontumor samples taken from nine patients with longstanding ulcerative colitis and colorectal carcinoma. Two of nine invasive carcinomas contained a K-ras mutation. By a combination of immunohistochemistry and single-strand conformation polymorphism analysis, p53 alterations were found in three of nine carcinomas. Five of 13 dysplastic lesions harbored a mutated K-ras gene, even in the absence of detectable changes in associated invasive tumors. One single focus of dysplastic mucosa harbored concomitant K-ras and p53 gene alterations. In two patients, a K-ras mutation was detected in epithelial lesions considered to be devoid of malignant potential (villous regeneration, active colitis). Our results indicate that: 1) the prevalence of K-ras and p53 genetic alterations found in ulcerative colitis-associated colonic carcinomas appears to be lower than in sporadic carcinomas; 2) K-ras mutations can be detected in dysplasia, villous regeneration, and active colitis and affect a subpopulation of the cells composing the lesions; 3) diverse genetic alterations can be detected in the same patient and the dysplastic lesions can exhibit a different genotype than the carcinomas; and 4) at least part of active colitis and villous regeneration lesions should be considered as preneoplastic in ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8160776      PMCID: PMC1887244     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  27 in total

Review 1.  A genetic model for colorectal tumorigenesis.

Authors:  E R Fearon; B Vogelstein
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

2.  Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.

Authors:  M Orita; H Iwahana; H Kanazawa; K Hayashi; T Sekiya
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

3.  c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma.

Authors:  G C Burmer; D S Levine; B G Kulander; R C Haggitt; C E Rubin; P S Rabinovitch
Journal:  Gastroenterology       Date:  1990-08       Impact factor: 22.682

4.  Prevalence of ras gene mutations in human colorectal cancers.

Authors:  J L Bos; E R Fearon; S R Hamilton; M Verlaan-de Vries; J H van Boom; A J van der Eb; B Vogelstein
Journal:  Nature       Date:  1987 May 28-Jun 3       Impact factor: 49.962

5.  The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes.

Authors:  L A Sternberger; P H Hardy; J J Cuculis; H G Meyer
Journal:  J Histochem Cytochem       Date:  1970-05       Impact factor: 2.479

6.  Villous regeneration in ulcerative colitis.

Authors:  R G Lee
Journal:  Arch Pathol Lab Med       Date:  1987-03       Impact factor: 5.534

7.  Activation of c-Ki-ras in human gastrointestinal dysplasias determined by direct sequencing of polymerase chain reaction products.

Authors:  S J Meltzer; S M Mane; P K Wood; J H Resau; C Newkirk; J A Terzakis; B I Korelitz; W M Weinstein; S W Needleman
Journal:  Cancer Res       Date:  1990-06-15       Impact factor: 12.701

8.  Villous dysplasia. An ominous histologic sign in colitic patients.

Authors:  C A Rubio; C Johansson; P Slezak; U Ohman; C Hammarberg
Journal:  Dis Colon Rectum       Date:  1984-05       Impact factor: 4.585

9.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.

Authors:  R H Riddell; H Goldman; D F Ransohoff; H D Appelman; C M Fenoglio; R C Haggitt; C Ahren; P Correa; S R Hamilton; B C Morson
Journal:  Hum Pathol       Date:  1983-11       Impact factor: 3.466

10.  Mammary origin of metastases. Immunohistochemical determination.

Authors:  P Chaubert; J Hurlimann
Journal:  Arch Pathol Lab Med       Date:  1992-11       Impact factor: 5.534

View more
  30 in total

1.  Epithelial proliferation and ras p21 oncoprotein expression in rectal mucosa of patients with ulcerative colitis.

Authors:  E Ierardi; M Principi; R Francavilla; S Passaro; F Noviello; O Burattini; A Francavilla
Journal:  Dig Dis Sci       Date:  2001-05       Impact factor: 3.199

Review 2.  Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences.

Authors:  Amosy E M'Koma; Harold L Moses; Samuel E Adunyah
Journal:  Int J Colorectal Dis       Date:  2011-02-11       Impact factor: 2.571

Review 3.  Molecular Alterations of Colorectal Cancer with Inflammatory Bowel Disease.

Authors:  Masakazu Yashiro
Journal:  Dig Dis Sci       Date:  2015-04-04       Impact factor: 3.199

4.  Study of p53 and bcl-2 Oncoproteins in Ulcerative Colitis with Dysplasia.

Authors:  P Kinra; Spv Turlapati; A Mehta; Ramji Rai
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 5.  Novel diagnostic and therapeutic techniques for surveillance of dysplasia in patients with inflammatory bowel disease.

Authors:  Marietta Iacucci; T Uraoka; M Fort Gasia; N Yahagi
Journal:  Can J Gastroenterol Hepatol       Date:  2014 Jul-Aug

6.  Peutz-Jeghers polyps, dysplasia, and K-ras codon 12 mutations.

Authors:  M M Entius; A M Westerman; F M Giardiello; M L van Velthuysen; M M Polak; R J Slebos; J H Wilson; S R Hamilton; G J Offerhaus
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

7.  Clinicopathological significance of Ki-ras point mutation and p21 expression in benign and malignant exocrine tumors of the human pancreas.

Authors:  M M Song; Y Nio; Y Sato; K Tamura; K Furuse
Journal:  Int J Pancreatol       Date:  1996-10

8.  Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium.

Authors:  S Fujii; T Fujimori; H Kawamata; J Takeda; K Kitajima; F Omotehara; T Kaihara; T Kusaka; K Ichikawa; Y Ohkura; Y Ono; J Imura; S Yamaoka; C Sakamoto; Y Ueda; T Chiba
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

9.  CD133, OCT4, and NANOG in ulcerative colitis-associated colorectal cancer.

Authors:  Hiromi Yasuda; Koji Tanaka; Yoshiki Okita; Toshimitsu Araki; Susumu Saigusa; Yuji Toiyama; Takeshi Yokoe; Shigeyuki Yoshiyama; Aya Kawamoto; Yasuhiro Inoue; Chikao Miki; Masato Kusunoki
Journal:  Oncol Lett       Date:  2011-09-06       Impact factor: 2.967

10.  Upregulation of p16(INK4A) and Bax in p53 wild/p53-overexpressing crypts in ulcerative colitis-associated tumours.

Authors:  T Yoshida; N Matsumoto; T Mikami; I Okayasu
Journal:  Br J Cancer       Date:  2004-09-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.